The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 26, 2013
Filed:
Aug. 07, 2012
Mark D. Wittman, Wallingford, CT (US);
Harold Mastalerz, Guilford, CT (US);
Kurt Zimmermann, Durham, CT (US);
Mark G. Saulnier, Higganum, CT (US);
Upender Velaparthi, Cheshire, CT (US);
Dolatrai M. Vyas, Madison, CT (US);
Guifen Zhang, Wallingford, CT (US);
Walter Lewis Johnson, Waterbury, CT (US);
David B. Frennesson, Naugatuck, CT (US);
Xiaopeng Sang, Glastonbury, CT (US);
Peiying Liu, Madison, CT (US);
David R. Langley, Meriden, CT (US);
Mark D. Wittman, Wallingford, CT (US);
Harold Mastalerz, Guilford, CT (US);
Kurt Zimmermann, Durham, CT (US);
Mark G. Saulnier, Higganum, CT (US);
Upender Velaparthi, Cheshire, CT (US);
Dolatrai M. Vyas, Madison, CT (US);
Guifen Zhang, Wallingford, CT (US);
Walter Lewis Johnson, Waterbury, CT (US);
David B. Frennesson, Naugatuck, CT (US);
Xiaopeng Sang, Glastonbury, CT (US);
Peiying Liu, Madison, CT (US);
David R. Langley, Meriden, CT (US);
Bristol-Myers Squibb Company, Princeton, NJ (US);
Abstract
The invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's Disease.